Olmeraas CH 40mg/12.5mg Tablet
Marketer
Zenni Pharmaceutical Private Limited
Salt Composition
Olmesartan Medoxomil (40mg) + Chlorthalidone (12.5mg)
Overview Olmeraas CH 40mg/12.5mg Tablet
Cardio-Guard 40mg/12.5mg tablets combine two active ingredients to manage hypertension through complementary mechanisms. Untreated high blood pressure significantly increases the risk of stroke, heart attack, and kidney disease. Cardio-Guard may be taken with or without food; dosage is individualized based on your response and health status. Consistent daily dosing is crucial for effectiveness. Continue treatment as directed by your physician. The formulation includes a diuretic, promoting increased urination, so avoid taking it within four hours of bedtime. Regular use is vital, even when feeling well, as hypertension often presents without symptoms. Discontinuing treatment elevates the risk of cardiovascular events. Dizziness is the most frequent side effect; others include fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is an intended effect of the diuretic component and contributes to blood pressure control. While uncommon, other side effects are possible. Consult the patient information leaflet and report persistent or bothersome side effects to your doctor, who may adjust your dosage or prescribe an alternative. This medication is unsuitable during pregnancy. If you have kidney or liver impairment, cardiac issues, or diabetes, seek your physician's advice before initiating treatment. Alcohol consumption may exacerbate hypotension and side effects.
Primary Ingredients of Olmeraas CH 40mg/12.5mg Tablet
No text was provided to rewrite.
Uses of Olmeraas CH 40mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmeraas CH 40mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmeraas CH 40mg/12.5mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Olmeraas CH 40mg/12.5mg Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use Olmeraas CH 40mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Olmeraas CH 40mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, though consistent timing is recommended.
How Olmeraas CH 40mg/12.5mg Tablet works:
Each Olmeraas CH tablet (40mg/12.5mg) contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Olmeraas CH 40mg/12.5mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Olmeraas CH 40mg/12.5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it is contraindicated. Nevertheless, a physician might exceptionally prescribe it in severe, life-threatening circumstances where the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmeraas CH 40mg/12.5mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Olmeraas CH 40mg/12.5mg tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should use Olmeraas CH 40mg/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. This medication is contraindicated in such cases.
LiverCAUTION
Caution is advised when prescribing Olmeraas CH 40mg/12.5mg Tablets to individuals with hepatic impairment; dosage modification may be necessary. Patients with severe liver disease should not receive Olmeraas CH 40mg/12.5mg Tablets. Physician consultation is recommended.
What if you forget to take Olmeraas CH 40mg/12.5mg Tablet :
Should you forget to take your Olmeraas CH 40mg/12.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmeraas CH 40mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |


